BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao R, Kong C, Li H, Huang L, Qu X, Qin N, Qin H. Dysbiosis signature of mycobiota in colon polyp and colorectal cancer. Eur J Clin Microbiol Infect Dis 2017;36:2457-68. [DOI: 10.1007/s10096-017-3085-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Hoggard M, Vesty A, Wong G, Montgomery JM, Fourie C, Douglas RG, Biswas K, Taylor MW. Characterizing the Human Mycobiota: A Comparison of Small Subunit rRNA, ITS1, ITS2, and Large Subunit rRNA Genomic Targets. Front Microbiol 2018;9:2208. [PMID: 30283425 DOI: 10.3389/fmicb.2018.02208] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
2 Kaźmierczak-Siedlecka K, Roviello G, Catalano M, Polom K. Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers. Nutrients 2021;13:2674. [PMID: 34444834 DOI: 10.3390/nu13082674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kaźmierczak-Siedlecka K, Skonieczna-Żydecka K, Hupp T, Duchnowska R, Marek-Trzonkowska N, Połom K. Next-generation probiotics - do they open new therapeutic strategies for cancer patients? Gut Microbes 2022;14:2035659. [PMID: 35167406 DOI: 10.1080/19490976.2022.2035659] [Reference Citation Analysis]
4 Huët MAL, Lee CZ, Rahman S. A review on association of fungi with the development and progression of carcinogenesis in the human body. Curr Res Microb Sci 2022;3:100090. [PMID: 34917994 DOI: 10.1016/j.crmicr.2021.100090] [Reference Citation Analysis]
5 Vallianou N, Kounatidis D, Christodoulatos GS, Panagopoulos F, Karampela I, Dalamaga M. Mycobiome and Cancer: What Is the Evidence? Cancers (Basel) 2021;13:3149. [PMID: 34202433 DOI: 10.3390/cancers13133149] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Bishehsari F, Engen PA, Preite NZ, Tuncil YE, Naqib A, Shaikh M, Rossi M, Wilber S, Green SJ, Hamaker BR, Khazaie K, Voigt RM, Forsyth CB, Keshavarzian A. Dietary Fiber Treatment Corrects the Composition of Gut Microbiota, Promotes SCFA Production, and Suppresses Colon Carcinogenesis. Genes (Basel) 2018;9:E102. [PMID: 29462896 DOI: 10.3390/genes9020102] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 19.5] [Reference Citation Analysis]
7 Li JQ, Li JL, Xie YH, Wang Y, Shen XN, Qian Y, Han JX, Chen YX, Fang JY. Saccharomyces cerevisiae may serve as a probiotic in colorectal cancer by promoting cancer cell apoptosis. J Dig Dis 2020;21:571-82. [PMID: 33245627 DOI: 10.1111/1751-2980.12930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Richard ML, Sokol H. The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases. Nat Rev Gastroenterol Hepatol 2019;16:331-45. [PMID: 30824884 DOI: 10.1038/s41575-019-0121-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 80] [Article Influence: 20.0] [Reference Citation Analysis]
9 Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019;16:690-704. [PMID: 31554963 DOI: 10.1038/s41575-019-0209-8] [Cited by in Crossref: 164] [Cited by in F6Publishing: 150] [Article Influence: 54.7] [Reference Citation Analysis]
10 Gao R, Xia K, Wu M, Zhong H, Sun J, Zhu Y, Huang L, Wu X, Yin L, Yang R, Chen C, Qin H. Alterations of Gut Mycobiota Profiles in Adenoma and Colorectal Cancer. Front Cell Infect Microbiol 2022;12:839435. [DOI: 10.3389/fcimb.2022.839435] [Reference Citation Analysis]
11 Silva M, Brunner V, Tschurtschenthaler M. Microbiota and Colorectal Cancer: From Gut to Bedside. Front Pharmacol 2021;12:760280. [PMID: 34658896 DOI: 10.3389/fphar.2021.760280] [Reference Citation Analysis]
12 Spatz M, Richard ML. Overview of the Potential Role of Malassezia in Gut Health and Disease. Front Cell Infect Microbiol 2020;10:201. [PMID: 32528901 DOI: 10.3389/fcimb.2020.00201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Qin X, Gu Y, Liu T, Wang C, Zhong W, Wang B, Cao H. Gut mycobiome: A promising target for colorectal cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188489. [PMID: 33278512 DOI: 10.1016/j.bbcan.2020.188489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
14 Chin VK, Yong VC, Chong PP, Amin Nordin S, Basir R, Abdullah M. Mycobiome in the Gut: A Multiperspective Review. Mediators Inflamm 2020;2020:9560684. [PMID: 32322167 DOI: 10.1155/2020/9560684] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
15 Shen X, Li J, Li J, Zhang Y, Li X, Cui Y, Gao Q, Chen X, Chen Y, Fang JY. Fecal Enterotoxigenic Bacteroides fragilis-Peptostreptococcus stomatis-Parvimonas micra Biomarker for Noninvasive Diagnosis and Prognosis of Colorectal Laterally Spreading Tumor. Front Oncol 2021;11:661048. [PMID: 34046355 DOI: 10.3389/fonc.2021.661048] [Reference Citation Analysis]
16 Bridges KM, Greiner KA, Umar S. Deciphering the Colorectal Cancer Gut Microbiota: Association vs. Causality. Curr Colorectal Cancer Rep 2019;15:70-7. [DOI: 10.1007/s11888-019-00431-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
17 Habtemariam S. Berberine pharmacology and the gut microbiota: A hidden therapeutic link. Pharmacol Res. 2020;155:104722. [PMID: 32105754 DOI: 10.1016/j.phrs.2020.104722] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
18 Zhang D, Wang Y, Shen S, Hou Y, Chen Y, Wang T. The mycobiota of the human body: a spark can start a prairie fire. Gut Microbes 2020;11:655-79. [PMID: 32150513 DOI: 10.1080/19490976.2020.1731287] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
19 Sánchez-Alcoholado L, Ramos-Molina B, Otero A, Laborda-Illanes A, Ordóñez R, Medina JA, Gómez-Millán J, Queipo-Ortuño MI. The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response. Cancers (Basel) 2020;12:E1406. [PMID: 32486066 DOI: 10.3390/cancers12061406] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 17.0] [Reference Citation Analysis]
20 Jayasudha R, Das T, Kalyana Chakravarthy S, Sai Prashanthi G, Bhargava A, Tyagi M, Rani PK, Pappuru RR, Shivaji S. Gut mycobiomes are altered in people with type 2 Diabetes Mellitus and Diabetic Retinopathy. PLoS One 2020;15:e0243077. [PMID: 33259537 DOI: 10.1371/journal.pone.0243077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
21 Rhimi W, Theelen B, Boekhout T, Otranto D, Cafarchia C. Malassezia spp. Yeasts of Emerging Concern in Fungemia. Front Cell Infect Microbiol 2020;10:370. [PMID: 32850475 DOI: 10.3389/fcimb.2020.00370] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Anandakumar A, Pellino G, Tekkis P, Kontovounisios C. Fungal microbiome in colorectal cancer: a systematic review. Updates Surg 2019;71:625-30. [PMID: 31586311 DOI: 10.1007/s13304-019-00683-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
23 Kaźmierczak-Siedlecka K, Dvořák A, Folwarski M, Daca A, Przewłócka K, Makarewicz W. Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis. Cancers (Basel) 2020;12:E1326. [PMID: 32455985 DOI: 10.3390/cancers12051326] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
24 Li TH, Liu L, Hou YY, Shen SN, Wang TT. C-type lectin receptor-mediated immune recognition and response of the microbiota in the gut. Gastroenterol Rep (Oxf) 2019;7:312-21. [PMID: 31687150 DOI: 10.1093/gastro/goz028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
25 Abdillah A, Ranque S. Chronic Diseases Associated with Malassezia Yeast. J Fungi (Basel) 2021;7:855. [PMID: 34682276 DOI: 10.3390/jof7100855] [Reference Citation Analysis]
26 Zong Y, Zhou Y, Liao B, Liao M, Shi Y, Wei Y, Huang Y, Zhou X, Cheng L, Ren B. The Interaction Between the Microbiome and Tumors. Front Cell Infect Microbiol 2021;11:673724. [PMID: 34532297 DOI: 10.3389/fcimb.2021.673724] [Reference Citation Analysis]
27 Wu Y, Jiao N, Zhu R, Zhang Y, Wu D, Wang AJ, Fang S, Tao L, Li Y, Cheng S, He X, Lan P, Tian C, Liu NN, Zhu L. Identification of microbial markers across populations in early detection of colorectal cancer. Nat Commun 2021;12:3063. [PMID: 34031391 DOI: 10.1038/s41467-021-23265-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Yang Q, Ouyang J, Pi D, Feng L, Yang J. Malassezia in Inflammatory Bowel Disease: Accomplice of Evoking Tumorigenesis. Front Immunol 2022;13:846469. [DOI: 10.3389/fimmu.2022.846469] [Reference Citation Analysis]
29 Khalyfa AA, Punatar S, Aslam R, Yarbrough A. Exploring the Inflammatory Pathogenesis of Colorectal Cancer. Diseases 2021;9:79. [PMID: 34842660 DOI: 10.3390/diseases9040079] [Reference Citation Analysis]
30 Wu M, Li J, An Y, Li P, Xiong W, Li J, Yan D, Wang M, Zhong G. Chitooligosaccharides Prevents the Development of Colitis-Associated Colorectal Cancer by Modulating the Intestinal Microbiota and Mycobiota. Front Microbiol 2019;10:2101. [PMID: 31620100 DOI: 10.3389/fmicb.2019.02101] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
31 Zhang L, Zhan H, Xu W, Yan S, Ng SC. The role of gut mycobiome in health and diseases. Therap Adv Gastroenterol 2021;14:17562848211047130. [PMID: 34589139 DOI: 10.1177/17562848211047130] [Reference Citation Analysis]